Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
基本信息
- 批准号:RGPIN-2017-04392
- 负责人:
- 金额:$ 2.91万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bioenergetics is the process whereby energy is generated from glycolysis in eukaryotes in the form of ATP. Anaerobic glycolysis occurs in the cytosol, which converts glucose to lactate while generating 2 ATP per glucose molecule. Aerobic glycolysis is completed in the mitochondrion, producing 30-32 ATP from each molecule of glucose via oxidative phosphorylation (OXPHOS). The regulation of bioenergetics depends on whether mitochondria are present, glucose and oxygen levels, and the effects of other endogenous regulators. Hydrogen sulfide (H2S) is one important endogenous factor. Its production and biological importance in eukaryotes have been known for more than a decade. The research supported by my previous NSERC Discovery grants has demonstrated, confirmed by numerous reports from other researchers, that H2S is generated in both the cytosol and mitochondrion in mammalian cells and that H2S regulates mitochondrial ATP production, promotes mitochondrial biogenesis, and affects cell viability. Mature mammalian red blood cells (RBCs) do not possess mitochondria and their bioenergetics relies on anaerobic glycolysis whereas avian RBCs have functional mitochondria and their bioenergetics involves both anaerobic glycolysis and OXPHOS. Whether mammalian and avian RBCs use the same or different mechanisms to produce H2S is unknown. The roles of H2S in the regulation of bioenergetics as well as viability of RBCs, in the presence or absence of mitochondria, have not been studied.We hypothesize that H2S differentially regulates anaerobic glycolysis and OXPHOS in mammalian and avian RBCs, exerting different functional impacts on the function and survival of these cells. The objectives of this program are to examine, in mitochondrion-free mouse RBCs and mitochondrion-containing chicken RBCs, 1) the production of endogenous H2S and its regulation; 2) the effects of H2S on anaerobic glycolysis and OXPHOS and the underlying mechanisms; 3) the impact of H2S-regulated bioenergetics on cellular survival and functions; and 4) the effects of polysulfide on bioenergetics and cell survival in comparison with those of H2S. These short-term objectives align with the long-term objective of my research career, i.e. to elucidate the metabolism and biological importance of gasotransmitters, including H2S, in eukaryotes. The proposed program can help better understand how the bioenergetics of RBCs is regulated by H2S to sustain the lifespan of these cells. New light will be shed on the significance of evolutionary extrusion of the mitochondrion from mammalian RBCs in connection to endogenous H2S metabolism. The knowledge gained will also help to devise H2S-based strategies to specifically regulate bioenergetics-dependent cellular and body functions, such as optimized storage conditions for RBCs in vitro, high altitude adaptation where oxygen supply is limited, or exercise and physical activities.
生物能量学是指在真核生物中通过糖酵解以ATP的形式产生能量的过程。 无氧糖酵解发生在胞质溶胶中,其将葡萄糖转化为乳酸,同时每个葡萄糖分子产生2个ATP。有氧糖酵解在葡萄糖胞体中完成,通过氧化磷酸化(OXPHOS)从每个葡萄糖分子中产生30-32个ATP。 生物能量学的调节取决于线粒体是否存在、葡萄糖和氧水平以及其他内源性调节剂的作用。硫化氢(H2S)是一种重要的内源性因素。其生产和生物学的重要性在真核生物中已经知道了十多年。由我以前的NSERC发现赠款支持的研究已经证明,由其他研究人员的许多报告证实,H2S在哺乳动物细胞的胞质溶胶和胞浆中产生,并且H2S调节线粒体ATP的产生,促进线粒体生物合成,并影响细胞活力。成熟的哺乳动物红细胞(RBC)不具有线粒体,并且它们的生物能学依赖于无氧糖酵解,而禽类RBC具有功能性线粒体,并且它们的生物能学涉及无氧糖酵解和OXPHOS。哺乳动物和鸟类红细胞是否使用相同或不同的机制来产生H2S尚不清楚。H2S在调节红细胞的生物能学以及生存能力中的作用,在线粒体存在或不存在的情况下,还没有studied.We假设,H2S差异调节哺乳动物和鸟类红细胞的无氧糖酵解和OXPHOS,对这些细胞的功能和生存产生不同的功能影响。本项目的目的是在无H2S的小鼠红细胞和含H2S的鸡红细胞中研究:1)内源性H2S的产生及其调节; 2)H2S对无氧糖酵解和OXPHOS的影响及其机制; 3)H2S调节的生物能量学对细胞存活和功能的影响;(4)与H_2S相比,多硫化物对生物能量学和细胞存活的影响。这些短期目标与我的研究生涯的长期目标,即阐明gasotransmitters,包括H2S,在真核生物的代谢和生物学的重要性。 拟议的计划可以帮助更好地了解红细胞的生物能量学如何受到H2S的调节,以维持这些细胞的寿命。新的光将阐明从哺乳动物红细胞连接内源性H2S代谢的进化挤压的意义。所获得的知识还将有助于设计基于H2S的策略,以专门调节生物能量依赖的细胞和身体功能,例如体外RBC的优化储存条件,氧气供应有限的高海拔适应,或运动和体育活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wang, Rui其他文献
In vitro and in vivo characterization of opioid activities of C-terminal esterified endomorphin-2 analogs
C 端酯化内吗啡肽 2 类似物的阿片类药物活性的体外和体内表征
- DOI:
10.1016/j.peptides.2009.06.003 - 发表时间:
2009-09 - 期刊:
- 影响因子:3
- 作者:
Wang, Chang-lin;Guo, Chao;Zhou, Ying;Wang, Rui - 通讯作者:
Wang, Rui
DegP primarily functions as a protease for the biogenesis of beta-barrel outer membrane proteins in the Gram-negative bacterium Escherichia coli
DegP 主要作为革兰氏阴性细菌大肠杆菌中 β-桶外膜蛋白生物发生的蛋白酶发挥作用
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:5.4
- 作者:
Ge, Xi;Wang, Rui;Ma, Jing;Liu, Yang;Ezemaduka, Anastasia N.;Chen, Peng R.;Fu, Xinmiao;Chang, Zengyi - 通讯作者:
Chang, Zengyi
The dimerization interface of the glycoprotein Ib beta transmembrane domain corresponds to polar residues within a leucine zipper motif
糖蛋白 Ib β 跨膜结构域的二聚化界面对应于亮氨酸拉链基序内的极性残基
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:8
- 作者:
Wei, Peng;Liu, Xin;Hu, Miao-Hui;Zuo, Li-Min;Kai, Ming;Wang, Rui;Luo, Shi-Zhong - 通讯作者:
Luo, Shi-Zhong
Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice
神经肽 FF 受体拮抗剂 RF9 减轻小鼠中枢注射 LPS 引起的发热
- DOI:
10.1016/j.peptides.2010.12.001 - 发表时间:
2011-04 - 期刊:
- 影响因子:3
- 作者:
Wang, Yi-qing;Wang, Sheng-bin;Ma, Jing-lin;Guo, Jia;Fang, Quan;Sun, Tao;Zhuanga, Yan;Wang, Rui - 通讯作者:
Wang, Rui
In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides
环缩肽氨基酸取代的新型放线菌素 D 类似物的体外和体内抗肿瘤作用
- DOI:
10.1016/j.peptides.2009.12.024 - 发表时间:
2010-04 - 期刊:
- 影响因子:3
- 作者:
Zhang, Bang-zhi;Wang, Kai-rong;Yan, Jie-xi;Zhang, Wei;Song, Jing-jing;Ni, Jing-man;Wang, Rui - 通讯作者:
Wang, Rui
Wang, Rui的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wang, Rui', 18)}}的其他基金
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2021
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2020
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2019
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2018
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2017
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Mitochondrial function by hydrogen sulfide
硫化氢对线粒体功能的调节
- 批准号:
171409-2012 - 财政年份:2016
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Mitochondrial function by hydrogen sulfide
硫化氢对线粒体功能的调节
- 批准号:
171409-2012 - 财政年份:2015
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
H2S-specific hypoxic Glove Box and a novel protein detection instrument for examining the effects of H2S on mitochondrial bioenergetics
H2S 特异性低氧手套箱和新型蛋白质检测仪器,用于检查 H2S 对线粒体生物能的影响
- 批准号:
RTI-2016-00007 - 财政年份:2015
- 资助金额:
$ 2.91万 - 项目类别:
Research Tools and Instruments
Development of biochemical formulations for in-vitro diagnostics
体外诊断生化制剂的开发
- 批准号:
484819-2015 - 财政年份:2015
- 资助金额:
$ 2.91万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Research and Development of a Liposomal Drug Formulation
脂质体药物制剂的研发
- 批准号:
468709-2014 - 财政年份:2014
- 资助金额:
$ 2.91万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
相似国自然基金
高质子选择性与高质子电导率的薄层复合阳离子交换膜的制备及其在反向电渗析(RED)技术中的应用研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RED重组酶与内源Ku蛋白在莱茵衣藻核基因同源重组定向改造中的相互作用分析
- 批准号:31870343
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
利用Red/ET DNA重组工程改造蛋白酶体抑制剂syrbactins生物合成途径开发抗肿瘤药物
- 批准号:31670097
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
面向RED路由器队列的LDoS攻击检测和防御方法的研究
- 批准号:61601467
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
一个用于表达黏细菌天然产物的底盘菌的优化及应用
- 批准号:31670098
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
抗肿瘤肽类化合物polytheonamides的异源表达及肿瘤靶向治疗研究
- 批准号:81502962
- 批准年份:2015
- 资助金额:17.9 万元
- 项目类别:青年科学基金项目
谷氨酸棒杆菌新型高效基因表达及打靶系统的构建
- 批准号:31370141
- 批准年份:2013
- 资助金额:78.0 万元
- 项目类别:面上项目
λ Red系统引入抗性的去除与APEC突变株致病作用的放大
- 批准号:31272559
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
噬菌体Red重组系统用于高等植物叶绿体转化的研究
- 批准号:31060160
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:地区科学基金项目
鸭大肠杆菌marA和acrB单基因缺失株的构建与多重耐药的调控机制
- 批准号:31072170
- 批准年份:2010
- 资助金额:38.0 万元
- 项目类别:面上项目
相似海外基金
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
- 批准号:
10584768 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Far Red Light to Improve Functioning in PAD: the LIGHT PAD Trial
远红光改善 PAD 功能:LIGHT PAD 试验
- 批准号:
10572758 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines
用于高效生产疟疾疫苗的条件性雄性致死史氏按蚊品系
- 批准号:
10602811 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease
一种与模态无关的效力测定,可实现镰状细胞病的体外和体内基因组编辑治疗
- 批准号:
10668694 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
- 批准号:
10639102 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Illuminating IL-31-producing cells in allergic skin disease
照亮过敏性皮肤病中产生 IL-31 的细胞
- 批准号:
10729476 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别: